512 related articles for article (PubMed ID: 16634070)
21. Long-term outcomes of stereotactic breast biopsies.
Makoske T; Preletz R; Riley L; Fogarty K; Swank M; Cochrane P; Blisard D
Am Surg; 2000 Dec; 66(12):1104-8; discussion 1108-9. PubMed ID: 11149580
[TBL] [Abstract][Full Text] [Related]
22. Touch imprint cytology of core needle biopsy specimens: a useful method for immediate reporting of symptomatic breast lesions.
Klevesath MB; Godwin RJ; Bannon R; Munthali L; Coveney E
Eur J Surg Oncol; 2005 Jun; 31(5):490-4. PubMed ID: 15922884
[TBL] [Abstract][Full Text] [Related]
23. The use of core biopsy imprint cytology in the 'one-stop' breast clinic.
Kulkarni D; Irvine T; Reyes RJ
Eur J Surg Oncol; 2009 Oct; 35(10):1037-40. PubMed ID: 19268520
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the clinical efficacy of minimally invasive procedures for breast cancer screening at a teaching hospital.
Verenhitach BD; Elias S; Patrocínio AC; Nazário AC; Waizberg A
J Clin Pathol; 2011 Oct; 64(10):858-61. PubMed ID: 21666140
[TBL] [Abstract][Full Text] [Related]
25. Multicenter evaluation of the breast lesion excision system, a percutaneous, vacuum-assisted, intact-specimen breast biopsy device.
Sie A; Bryan DC; Gaines V; Killebrew LK; Kim CH; Morrison CC; Poller WR; Romilly AP; Schilling K; Sung JH
Cancer; 2006 Sep; 107(5):945-9. PubMed ID: 16874817
[TBL] [Abstract][Full Text] [Related]
26. Stereotactic core biopsy of nonpalpable breast lesions.
Strong JW; Worsham GF; Austin RM; Gruber FH; Bagg MN
J S C Med Assoc; 1995 Dec; 91(12):489-96. PubMed ID: 8587312
[TBL] [Abstract][Full Text] [Related]
27. A retrospective study of the diagnostic accuracy of fine-needle aspiration for breast lesions and implications for future use.
Day C; Moatamed N; Fimbres AM; Salami N; Lim S; Apple SK
Diagn Cytopathol; 2008 Dec; 36(12):855-60. PubMed ID: 18855909
[TBL] [Abstract][Full Text] [Related]
28. Predictive power of cytomorphological features in equivocal (C3, C4) breast FNAC.
Moyes C; Dunne B
Cytopathology; 2004 Dec; 15(6):305-10. PubMed ID: 15606362
[TBL] [Abstract][Full Text] [Related]
29. Risk of needle tract seeding of breast cancer: cytological results derived from core wash material.
Uematsu T; Kasami M
Breast Cancer Res Treat; 2008 Jul; 110(1):51-5. PubMed ID: 17674195
[TBL] [Abstract][Full Text] [Related]
30. Comparison of fine needle aspiration and Tru-Cut biopsy of palpable mammary lesions.
Scopa CD; Koukouras D; Spiliotis J; Harkoftakis J; Koureleas S; Kyriakopoulou D; Tzoracoleftherakis E
Cancer Detect Prev; 1996; 20(6):620-4. PubMed ID: 8939348
[TBL] [Abstract][Full Text] [Related]
31. Negative predictive value of sonography and mammography in patients with focal breast pain.
Tumyan L; Hoyt AC; Bassett LW
Breast J; 2005; 11(5):333-7. PubMed ID: 16174154
[TBL] [Abstract][Full Text] [Related]
32. Benign breast lesions at risk of developing cancer--a challenging problem in breast cancer screening programs: five years' experience of the Breast Cancer Screening Program in Verona (1999-2004).
Manfrin E; Mariotto R; Remo A; Reghellin D; Falsirollo F; Dalfior D; Bricolo P; Piazzola E; Bonetti F
Cancer; 2009 Feb; 115(3):499-507. PubMed ID: 19117040
[TBL] [Abstract][Full Text] [Related]
33. [Non palpable lesions of the breast: the Mammotome-biopsy in the preoperative management of breast cancer].
Ceccarelli G; Casciola L; Battistini I; Stefanoni M; Spaziani A; Conti D; Di Zitti L; Valeri R; Bartoli A; Bellochi R; Rambotti M; Pisanelli MC
G Chir; 2005 May; 26(5):187-93. PubMed ID: 16184700
[TBL] [Abstract][Full Text] [Related]
34. Multitarget stereotactic core-needle breast biopsy (MSBB)--an effective and safe diagnostic intervention for non-palpable breast lesions: a large prospective single institution study.
Senn Bahls E; Dupont Lampert V; Oelschlegel C; Senn HJ
Breast; 2006 Jun; 15(3):339-46. PubMed ID: 16488609
[TBL] [Abstract][Full Text] [Related]
35. Modified core wash cytology (CWC), an asset in the diagnostic work-up of breast lesions.
Wauters CA; Sanders-Eras MC; de Kievit-van der Heijden IM; Wesseling P; Venderink DJ; van Dijk Azn R; van den Wildenberg F; Kooistra BW; Strobbe LJ
Eur J Surg Oncol; 2010 Oct; 36(10):957-62. PubMed ID: 20708371
[TBL] [Abstract][Full Text] [Related]
36. Predicting cancer on excision of atypical ductal hyperplasia.
Doren E; Hulvat M; Norton J; Rajan P; Sarker S; Aranha G; Yao K
Am J Surg; 2008 Mar; 195(3):358-61; discussion 361-2. PubMed ID: 18206849
[TBL] [Abstract][Full Text] [Related]
37. Histopathologic analysis of atypical lesions in image-guided core breast biopsies.
Bonnett M; Wallis T; Rossmann M; Pernick NL; Bouwman D; Carolin KA; Visscher D
Mod Pathol; 2003 Feb; 16(2):154-60. PubMed ID: 12591968
[TBL] [Abstract][Full Text] [Related]
38. Pseudoangiomatous stromal hyperplasia of the breast: a contemporary approach to its clinical and radiologic features and ideal management.
Gresik CM; Godellas C; Aranha GV; Rajan P; Shoup M
Surgery; 2010 Oct; 148(4):752-7; discussion 757-8. PubMed ID: 20708765
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the diagnostic accuracy of a vacuum-assisted percutaneous intact specimen sampling device to a vacuum-assisted core needle sampling device for breast biopsy: initial experience.
Killebrew LK; Oneson RH
Breast J; 2006; 12(4):302-8. PubMed ID: 16848839
[TBL] [Abstract][Full Text] [Related]
40. Screen-detected breast lesions with an indeterminate (B3) core needle biopsy should be excised.
Lieske B; Ravichandran D; Alvi A; Lawrence DA; Wright DJ
Eur J Surg Oncol; 2008 Dec; 34(12):1293-8. PubMed ID: 18162359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
